| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$7 |
Vintage and Vault sign HoA on gas sales from Cullen-1
|
21 Apr 2026 9:48AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
VEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Vintage and Vault sign Heads of Agreement for Cullen-1 gas sales
- Agreement subject to positive flow test results
- Cullen-1 is located in the Bonaparte Basin, Northern Territory
- Vault Energy plans to use gas for data center power generation
- The agreement includes information sharing and collaboration
- Cullen-1 showed strong gas indications but was never tested
- Access issues had previously delayed testing since 2019
- The agreement is part of a 'Well to Wire' power model
- Northern Territory Government provides path for environmental applications
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$36 |
Update - Notification of buy-back - TEK
|
21 Apr 2026 9:47AM |
$0.100 |
$0.097 |
fallen by
3%
|
|
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
Skin Cancer Trial Moves to BCC With More Encouraging Signals
|
21 Apr 2026 9:46AM |
$0.061 |
$0.059 |
fallen by
3.28%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Expansion into Basal Cell Carcinoma (BCC) patients in the NMSC trial.
- Approval from the Safety Review Committee (SRC) based on SCC results.
- Strong safety data with no adverse effects observed.
- Reduction in lesion size and complete resolution in some cases.
- BCC accounts for 80% of all skin cancers.
- Significant milestone for INV043 and future Phase II strategy.
- Upcoming anogenital trial to use the same formulation of INV043.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$224 |
Appointment of Chief Solutions Officer for Nol8
|
21 Apr 2026 9:45AM |
$0.660 |
$0.700 |
risen by
6.06%
|
|
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,317 |
Cleansing Notice
|
21 Apr 2026 9:44AM |
$0.300 |
$0.260 |
fallen by
13.33%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$87 |
Update - Notification of buy-back - TOP
|
21 Apr 2026 9:44AM |
$0.530 |
$0.515 |
fallen by
2.83%
|
|
| Great Southern Mining Limited (GSN) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
21 Apr 2026 9:43AM |
$0.025 |
$0.021 |
fallen by
16%
|
|
GSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Commencement of deep diamond drilling at Golden Boulder.
- Assay results indicate a 3.5km strike of gold mineralization.
- Completion of a deep diamond hole at the Diorite Hill targeting PGE-Nickel-Copper.
- A$4.2 million raised through equity placement.
- A$5.6 million cash on hand at quarter-end.
- Net cash used in operating activities was A$295,000.
- Significant exploration and evaluation investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lark Distilling Co. Ltd (LRK) ORDINARY FULLY PAID |
Consumer Staple |
$93 |
March 2026 Quarterly Update and Appendix 4C
|
21 Apr 2026 9:43AM |
$0.860 |
$0.870 |
risen by
1.16%
|
|
LRK - Price-sensitive ASX Announcement
Full Release
Key Points
- Net sales of $4.3 million, up 0.2% from the prior corresponding period.
- Launch of new Signature Whisky Range with international recognition.
- Domestic Direct-to-Consumer sales decreased due to timing of releases.
- Global Travel Retail sales increased by 42%.
- Strong domestic Business-to-Business growth.
- Cash holdings of $15.8 million as of 31 March 2026.
- Whisky Bank holds approximately 2.4 million liters.
- Net cash outflow from operating activities was $2.1 million.
- New range launch recognized at World Whiskies Awards.
- Strategic growth initiatives supported by strong financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$8 |
SRR: Corporate Update - Exploration and Arbitration
|
21 Apr 2026 9:42AM |
$0.029 |
$0.030 |
risen by
3.45%
|
|
| Sarama Resources Ltd (SRR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$17 |
Corporate Update - Exploration and Arbitration
|
21 Apr 2026 9:42AM |
$0.038 |
$0.036 |
fallen by
5.26%
|
|
SRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Sarama Resources Ltd has entered into a Share Sale Agreement with Riedel Resources Ltd to sell its Cosmo and Mt Venn Projects in exchange for equity and expense payments.
- Sarama will receive 150 million shares and 100 million performance rights in Riedel, with project-related costs capped at A$300,000.
- The performance rights are structured in tranches, vesting upon achieving specific project milestones.
- Riedel has received commitments to raise A$2.5 million for exploration and working capital.
- Sarama is pursuing an arbitration claim against the Government of Burkina Faso for US$242 million over the expropriation of its Tankoro 2 Exploration Permit.
- The arbitration proceedings are scheduled to culminate in a Merits Hearing in February 2027.
- Sarama has secured a US$4.4 million funding facility to cover legal fees for the arbitration.
- Sarama has also secured early-stage copper-gold exploration tenements in New South Wales, Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$1,931 |
March 2026 Quarterly Activities and Cash Flow
|
21 Apr 2026 9:42AM |
$11.750 |
$13.170 |
risen by
12.09%
|
|
SRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of the Syerston Scandium Project Feasibility Study indicating strong economics for the project.
- The project's capital efficiency with a development cost of approximately US$120 million.
- Forecast of producing 60 tonnes per year of scandium oxide with low operating costs.
- Engagement with U.S. scandium users due to increased demand and restricted supply from China.
- Sunrise Energy Metals included in the S&P/ASX All Ordinaries Index.
- Significant increase in cash inflow mainly from capital raising and the exercise of unlisted options.
- Net cash used in operating activities for the quarter was AU$2,142,000.
- The Company maintains full equity interest in its mineral tenements.
- The announcement was authorized by the Board of Directors of Sunrise Energy Metals Limited.
- Estimated quarters of funding available based on cash flow projections is 54.7 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mineral Resources Limited (MIN) ORDINARY FULLY PAID |
Materials |
$13,696 |
MIN prices US$1.3 Billion Senior Unsecured Notes Offering
|
21 Apr 2026 9:42AM |
$62.250 |
$69.300 |
risen by
11.33%
|
|
MIN - Price-sensitive ASX Announcement
Full Release
Key Points
- Mineral Resources Limited (MinRes) announced the pricing of US$1.3 billion Senior Unsecured Notes.
- The offering consists of US$650 million 6.000% Notes due 2032 and US$650 million 6.250% Notes due 2034.
- The Notes are offered to qualified institutional buyers and certain persons outside the United States.
- Settlement is expected on 29 April 2026 in New York, subject to closing conditions.
- MinRes will use proceeds to refinance existing debt, repay iron ore prepayment, and redeem certain other notes.
- Expected finance cost savings of $48 million per annum.
- Weighted average cost of debt to decrease from 8.4% to 7.4%.
- The offering extends the company’s debt tenor from 3.1 years to 5.0 years.
- The transaction does not constitute an offer to sell the Notes publicly.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - RIE
|
21 Apr 2026 9:42AM |
$0.029 |
$0.030 |
risen by
3.45%
|
|
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$8 |
Riedel Resources Makes Transformational Gold Acquisition
|
21 Apr 2026 9:42AM |
$0.029 |
$0.030 |
risen by
3.45%
|
|
RIE - Price-sensitive ASX Announcement
Full Release
Key Points
- Riedel acquires Cosmo and Mt Venn Projects in Western Australia.
- Projects cover approximately 1,000km² in the Laverton Gold District.
- Strategically located near major gold producers like Gruyere and Duketon.
- Includes issuance of shares and performance rights to Sarama Resources.
- Concurrent A$2.5 million equity placement to fund exploration.
- Transaction completion expected in June 2026, pending approvals.
- Riedel aims to conduct systematic and modern exploration.
- Addition of experienced mining executives to Riedel's team.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sarama Resources Ltd (SRR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$17 |
RIE:Riedel Resources Makes Transformational Gold Acquisition
|
21 Apr 2026 9:42AM |
$0.038 |
$0.036 |
fallen by
5.26%
|
|
| Jupiter Energy Limited (JPR) ORDINARY FULLY PAID |
Energy |
$35 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
21 Apr 2026 9:41AM |
$0.028 |
$0.027 |
fallen by
3.57%
|
|
JPR - Price-sensitive ASX Announcement
Full Release
Key Points
- Oil sales revenue for the quarter ending 31 March 2026 totaled ~$US1.68m/~$A2.4m.
- Approximately 38,000 barrels of oil were sold into the Kazakh domestic market.
- No oil sales were made into the export market during the quarter.
- The company's production wells continued to operate under full commercial licenses.
- Major production fields included Akkar North, Akkar East, and West Zhetybai.
- Cash receipts for the quarter were approximately ~$A2.356m.
- The company's total debt remained interest-free until at least 31 December 2026.
- Net cash reserves at the end of the quarter were approximately ~$A0.725m.
- The company does not plan to raise more cash but expects strong sales revenues in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,317 |
Application for quotation of securities - EQR
|
21 Apr 2026 9:40AM |
$0.300 |
$0.260 |
fallen by
13.33%
|
|
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$57 |
Section 708A Cleansing Statement
|
21 Apr 2026 9:40AM |
$0.087 |
$0.077 |
fallen by
11.49%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$309 |
FDA confirms path to DEP HER2 first-in-human study
|
21 Apr 2026 9:40AM |
$0.680 |
$0.735 |
risen by
8.09%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA confirms path for DEP® HER2 first-in-human study.
- Study targets unmet needs in advanced HER2-expressing cancers.
- FIH phase 1 study to begin in Europe in H2 CY 2026.
- Starpharma's dendrimer platform aims to enhance radiotherapy applications.
- Positive FDA feedback suggests potential for Fast Track designation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$30 |
Scheme Update
|
21 Apr 2026 9:39AM |
$0.095 |
$0.098 |
risen by
3.16%
|
|
LGP - Price-sensitive ASX Announcement
Full Release
Key Points
- LGP postpones Scheme Consideration Resolution to May 22, 2026.
- Proposed acquisition of Cannatrek Ltd by LGP is through a scheme of arrangement.
- The scheme is subject to satisfying certain Conditions Precedent.
- LGP operates significant production facilities in Denmark and Australia.
- LGP is a leading supplier in the medicinal cannabis market in Australia, France, Germany, and the UK.
- Updated timetable for the scheme to be provided once finalized.
- LGP encourages shareholders to receive communications electronically.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VHM Limited (VHM) ORDINARY FULLY PAID |
Materials |
$79 |
Trading Halt
|
21 Apr 2026 9:39AM |
$0.325 |
$0.255 |
fallen by
21.54%
|
|
VHM - Price-sensitive ASX Announcement
Full Release
Key Points
- VHM Limited requested a trading halt on 21 April 2026.
- The halt is related to a proposed equity capital raising.
- The halt will last until the announcement is made or trading resumes on 22 April 2026.
- VHM is not aware of reasons against the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Compumedics Limited (CMP) ORDINARY FULLY PAID |
Health Care |
$59 |
Business Update April 2026
|
21 Apr 2026 9:38AM |
$0.285 |
$0.295 |
risen by
3.51%
|
|
CMP - Price-sensitive ASX Announcement
Full Release
Key Points
- Compumedics reports strong demand across platforms despite timing issues impacting FY26.
- Sales momentum continues in sleep and neurology platforms, with growth in SaaS and annuity revenues.
- MEG business experiences delays due to helium supply constraints, deferring some revenue to FY27.
- Leadership changes and cost realignment in the US aim to improve performance.
- Expected revenue growth for FY26 is 22% to 28% over FY25, with EBITDA between $5.5 million and $7 million.
- Company maintains strong liquidity with $10 to $11 million available.
- Focus remains on strategic execution and growth initiatives for improved performance in FY27.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$132 |
Trading Halt
|
21 Apr 2026 9:36AM |
$0.080 |
$0.059 |
fallen by
26.25%
|
|
RML - Price-sensitive ASX Announcement
Full Release
Key Points
- Resolution Minerals Ltd requested a trading halt.
- The halt is pending a material capital raise announcement.
- The trading halt will last until the announcement or the start of trading on 23 April 2026.
- Resolution Minerals Ltd is not aware of any reason not to grant the halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bass Oil Limited (BAS) ORDINARY FULLY PAID |
Energy |
$21 |
Operations Update - March 2026
|
21 Apr 2026 9:35AM |
$0.060 |
$0.056 |
fallen by
6.67%
|
|
BAS - Price-sensitive ASX Announcement
Full Release
Key Points
- Cooper Basin trucking recommenced in early April.
- 2,197 barrels were sold in the first week at A$186.38 per barrel.
- Worrior facility recorded 96% uptime.
- Padulla facility was shut down but resumed production in April.
- Bass Oil is acquiring 100% of the Vanessa Gas Field.
- Gas sales from Vanessa expected in the second half of 2026.
- The Kiwi field development received $3.5 million in grant funding.
- Indonesian production was 4,268 barrels in March.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$57 |
Application for quotation of securities - NUZ
|
21 Apr 2026 9:33AM |
$0.087 |
$0.077 |
fallen by
11.49%
|
|
Call 1300 880 160
Start a chat
Schedule a call
